US 11197870
Treatment for hepatic fibrosis
granted A61KA61K31/192A61K31/4439
Quick answer
US patent 11197870 (Treatment for hepatic fibrosis) held by GALMED RESEARCH AND DEVELOPMENT LTD expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GALMED RESEARCH AND DEVELOPMENT LTD
- Grant date
- Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/192, A61K31/4439, A61K31/55, A61K31/575